Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ritsuko Hanajima

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 19, 2023
Roles of the cerebellum and basal ganglia in temporal integration: Insights from a synchronized tapping taskShin-Ichi Tokushige, Shunichi Matsuda, Masayoshi Tada, et al.
BMJ Open|December 5, 2019
Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patientsKeiko Imamura, Yuishin Izumi, Haruhiko Banno, et al.
Eclinicalmedicine|December 5, 2022
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trialKeiko Imamura, Yuishin Izumi, Makiko Nagai, et al.
Journal of Alzheimer'S Disease Reports|January 1, 2026
Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD)Hiroaki Shimokawa, Masahiro Akishita, Takashi Asada, et al.
Journal of Neurology|January 20, 2020
Cognitive and behavioral status in Japanese ALS patients: a multicenter studyYasuhiro Watanabe, Joost Raaphorst, Yuishin Izumi, et al.
BMJ Open|October 26, 2024
Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) studyKeiko Imamura, Yuishin Izumi, Naohiro Egawa, et al.
Eclinicalmedicine|May 31, 2023
High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trialJun Mitsui, Takashi Matsukawa, Yukari Uemura, et al.
Neuroradiology|July 22, 2024
Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC studyKeita Sakurai, Aya M Tokumaru, Mari Yoshida, et al.
Brain Communications|December 13, 2023
Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndromeIkuko Aiba, Yuichi Hayashi, Takayoshi Shimohata, et al.
Nature Genetics|March 7, 2018
Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsyHiroyuki Ishiura, Koichiro Doi, Jun Mitsui, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 19, 2023
Roles of the cerebellum and basal ganglia in temporal integration: Insights from a synchronized tapping taskShin-Ichi Tokushige, Shunichi Matsuda, Masayoshi Tada, et al.
BMJ Open|December 5, 2019
Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patientsKeiko Imamura, Yuishin Izumi, Haruhiko Banno, et al.
Eclinicalmedicine|December 5, 2022
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trialKeiko Imamura, Yuishin Izumi, Makiko Nagai, et al.
Journal of Alzheimer'S Disease Reports|January 1, 2026
Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD)Hiroaki Shimokawa, Masahiro Akishita, Takashi Asada, et al.
Journal of Neurology|January 20, 2020
Cognitive and behavioral status in Japanese ALS patients: a multicenter studyYasuhiro Watanabe, Joost Raaphorst, Yuishin Izumi, et al.
BMJ Open|October 26, 2024
Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) studyKeiko Imamura, Yuishin Izumi, Naohiro Egawa, et al.
Eclinicalmedicine|May 31, 2023
High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trialJun Mitsui, Takashi Matsukawa, Yukari Uemura, et al.
Neuroradiology|July 22, 2024
Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC studyKeita Sakurai, Aya M Tokumaru, Mari Yoshida, et al.
Brain Communications|December 13, 2023
Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndromeIkuko Aiba, Yuichi Hayashi, Takayoshi Shimohata, et al.
Nature Genetics|March 7, 2018
Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsyHiroyuki Ishiura, Koichiro Doi, Jun Mitsui, et al.
Pageof 15